OpenAI released Rosalind Workbench, a unified environment that consolidates fragmented scientific tools and data into one workspace for life science researchers. It's built on GPT-Rosalind, a specialized model for biology, and available through ChatGPT with guided workflows for tasks like protein design, genomics analysis, and molecular docking.

• Solves a real workflow problem: researchers currently juggle data in one system, analysis in another, and experimental records elsewhere, losing context between steps
• Includes specialized viewers and guided tasks (protein design, small-molecule design, genomics, experimental validation) that keep biological questions connected across different tools
• Offers two access modes—Explore mode for general questions and Research mode for complex analysis, with verified organizations able to request access now and individual access coming later

Claude for Healthcare is now available, providing HIPAA-compliant tools for healthcare providers and patients to improve medical processes such as prior authorizations and claims appeals. Additionally, Claude for Life Sciences has expanded its capabilities to better support clinical trial operations and regulatory submissions. These advancements aim to streamline healthcare tasks and enhance the quality of patient care.

• Claude for Healthcare launches with HIPAA-compliant tools plus connectors to CMS Coverage Database, ICD-10, and the NPI Registry for faster data retrieval and report generation
• New Agent Skills target prior authorization reviews and interoperability, letting organizations customize workflows to speed approvals and support claims appeals
• Opus 4.5's improved medical/scientific performance extends Claude's use into ambient scribing, clinical decision support, and personal health data summarization for individual users
• Claude for Life Sciences adds integrations with Medidata and ClinicalTrials.gov to support clinical trial patient recruitment, protocol design, and access to historical trial data